Miromatrix Medical Inc. MIRO NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score

54/100

2/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Miromatrix Medical Inc. (MIRO), dont 29 achats et 18 ventes. Le total des achats d'initiés s'élève à $999.39K et le total des ventes d'initiés à $2.08M.

Les initiés notables ayant une activité récente comprennent Kattungal Laji, Erb John L, Buckman Paul. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — MIRO

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2024-07-16	Kattungal Laji	Vice President of Quality	Cession	80,000	$3.75	$300K	-
2023-12-13	Erb John L	Director	Restitution d'Actions	25,000	$3.75	$93.75K	-
2023-12-13	Buckman Paul	Director	Restitution d'Actions	25,000	$3.75	$93.75K	-
2023-12-13	Maag Peter	Director	Restitution d'Actions	58,368	-	-	-
2023-12-13	Burke William P. Mr.	Director	Restitution d'Actions	67,413	-	-	-
2023-12-13	Heine Lisa Wipperman	Director	Restitution d'Actions	67,413	-	-	-
2023-12-13	Ross Jeffrey James	Chief Executive Officer	Restitution d'Actions	100,000	$3.26	$326K	-
2023-12-13	Douglas James Michael	Chief Financial Officer	Restitution d'Actions	40,000	$3.26	$130.4K	-
2023-12-12	Erb John L	Director	OPA (Vente)	56,260	$1.75	$98.46K	54,201
2023-12-12	Buckman Paul	Director	OPA (Vente)	52,593	$1.75	$92.04K	54,201
2023-12-12	Maag Peter	Director	OPA (Vente)	62,092	$1.75	$108.66K	58,368
2023-12-12	Burke William P. Mr.	Director	OPA (Vente)	66,943	$1.75	$117.15K	67,413
2023-12-12	Heine Lisa Wipperman	Director	OPA (Vente)	66,943	$1.75	$117.15K	67,413
2023-12-12	Ross Jeffrey James	Chief Executive Officer	OPA (Vente)	308,775	$1.75	$540.36K	87,500
2023-12-12	Douglas James Michael	Chief Financial Officer	OPA (Vente)	31,250	$1.75	$54.69K	20,000
2023-12-12	United Therapeutics Corp	10 Percent Owner	Cession	-	-	-	27,419,228
2023-06-01	Erb John L	Director	Attribution de RSU	54,201	-	-	110,461
2023-06-01	Buckman Paul	Director	Attribution de RSU	54,201	-	-	106,794
2023-06-01	Maag Peter	Director	Attribution de RSU	54,201	-	-	120,460
2023-06-01	Burke William P. Mr.	Director	Attribution de RSU	54,201	-	-	134,356
2023-06-01	Heine Lisa Wipperman	Director	Attribution de RSU	54,201	-	-	134,356
2023-03-10	Erb John L	Director	Achat Informatif	31,250	$1.60	$50K	56,260
2023-03-10	Buckman Paul	Director	Achat Informatif	31,250	$1.60	$50K	52,593
2023-03-10	Maag Peter	Director	Achat Informatif	31,250	$1.60	$50K	66,259
2023-03-10	Burke William P. Mr.	Director	Achat Informatif	31,250	$1.60	$50K	80,155
2023-03-10	Heine Lisa Wipperman	Director	Achat Informatif	31,250	$1.60	$50K	80,155
2023-03-10	Ross Jeffrey James	Chief Executive Officer	Achat Informatif	31,250	$1.60	$50K	396,276
2023-03-10	Barry John Joseph	Vice President of R&d	Achat Informatif	6,250	$1.60	$10K	35,485
2023-03-10	Douglas James Michael	Chief Financial Officer	Achat Informatif	31,250	$1.60	$50K	51,250
2023-01-13	Ross Jeffrey James	Chief Executive Officer	Attribution de RSU	100,000	-	-	100,000
2023-01-13	Barry John Joseph	Vice President of R&d	Attribution de RSU	20,000	-	-	20,000
2023-01-13	Douglas James Michael	Chief Financial Officer	Attribution de RSU	20,000	-	-	20,000
2022-12-06	Ross Jeffrey James	Chief Executive Officer	Exercice d'Options (Vente)	37,500	-	-	-
2022-10-01	Barry John Joseph	Vice President of R&d	Retenue Fiscale RSU	765	$4.38	$3.35K	19,235
2022-08-10	Erb John L	Director	Attribution de RSU	12,788	-	-	25,010
2022-08-10	Buckman Paul	Director	Attribution de RSU	12,788	-	-	21,343
2022-08-10	Maag Peter	Director	Attribution de RSU	12,788	-	-	35,009
2022-08-10	Burke William P. Mr.	Director	Attribution de RSU	12,788	-	-	48,905
2022-08-10	Heine Lisa Wipperman	Director	Attribution de RSU	12,788	-	-	48,905
2022-03-15	Ross Jeffrey James	Chief Executive Officer	Exercice d'Options	35,438	$1.25	$44.3K	293,588
2022-03-01	Douglas James Michael	Officer	Inconnu	-	-	-	-
2022-03-01	Douglas James Michael	Chief Financial Officer	Attribution de RSU	180,000	-	-	180,000
2022-01-13	Niebur Brian	Chief Financial Officer	Attribution de RSU	20,000	$4.20	$84K	20,000
2022-01-13	Kattungal Laji	Vice President of Quality	Attribution de RSU	10,000	-	-	10,000
2022-01-13	Ross Jeffrey James	Chief Executive Officer	Attribution de RSU	100,000	$4.20	$420K	100,000
2022-01-13	Barry John Joseph	Vice President of R&d	Attribution de RSU	20,000	$4.20	$84K	20,000
2022-01-03	Niebur Brian	Chief Financial Officer	Attribution de RSU	1,500	$4.73	$7.1K	1,500
2022-01-03	Burke William P. Mr.	Director	Inconnu	-	-	-	-
2022-01-03	Burke William P. Mr.	Director	Attribution de RSU	4,405	-	-	4,405
2022-01-03	Heine Lisa Wipperman	Director	Inconnu	-	-	-	-

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration